ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Alterity Therapeutics Limited

Alterity Therapeutics Limited (ATHE)

3,94
0,04
(1,03%)
Fermé 06 Juin 10:00PM
3,94
0,00
(0,00%)
Après les heures de négociation: 1:59AM

Alterity Therapeutics Limited (ATHE) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
3,94
( 1,03% )
Prix Achat
3,89
Prix Vente
4,37
Volume échangé
11 551
3,89 Fourchette du Jour 4,07
2,66 Plage de 52 semaines 7,00
Cap du marché
Clôture Veille
3,90
Ouverture
3,91
Dernière Transaction
5
@
3.89
Dernière heure de transaction
Volume financier
US$ 45 466
VWAP
3,9361
Volume moyen (3 m)
US$ 5 191 988
Actions en circulation
217 508 326
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-5,45
Bénéfice par action (BPA)
-0
Chiffre d'affairess (LTM)
6,64M
Bénéfice net (LTM)
-14,59M

À propos de Alterity Therapeutics Limited

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson’s disease. The company’s lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical tri... Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson’s disease. The company’s lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson’s disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as biomarkers of progression in multiple system atrophy. The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Siège social
Melbourne, Australia
Fondé
1997
Alterity Therapeutics Limited est coté dans le secteur Healthcare de la NASDAQ avec le ticker ATHE. Le dernier cours de clôture d'Alterity Therapeutics était de US$3,90. Au cours de la dernière année, les actions de Alterity Therapeutics ont été négociées dans une fourchette de prix de US$ 2,66 à US$ 7,00.

Alterity Therapeutics compte actuellement 217 508 326 actions en circulation. La capitalisation boursière d'Alterity Therapeutics est de US$856,98 million. Alterity Therapeutics a un ratio cours/bénéfice (ratio PE) de -5.45.

ATHE Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.12-2.955665024634.064.123.88162044.00792459DR
4-0.61-13.40659340664.554.953.84225614.22769678DR
120.349.444444444443.65.253.09209274.29133904DR
260.4813.87283236993.465.252.66170243.88167192DR
52-0.74-15.8119658124.6872.66499234.6255308DR
1561.0335.39518900342.9171.0011228344.00414551DR
2602.59191.8518518521.3570.295702801.95055776DR

ATHE - Frequently Asked Questions (FAQ)

What is the current Alterity Therapeutics Limited share price?
The current share price of Alterity Therapeutics Limited is US$ 3,94
How many Alterity Therapeutics Limited shares are in issue?
Alterity Therapeutics Limited has 217 508 326 shares in issue
What is the market cap of Alterity Therapeutics Limited?
The market capitalisation of Alterity Therapeutics Limited is USD 856,98M
What is the 1 year trading range for Alterity Therapeutics Limited share price?
Alterity Therapeutics Limited has traded in the range of US$ 2,66 to US$ 7,00 during the past year
What is the PE ratio of Alterity Therapeutics Limited?
The price to earnings ratio of Alterity Therapeutics Limited is -5,45
What is the cash to sales ratio of Alterity Therapeutics Limited?
The cash to sales ratio of Alterity Therapeutics Limited is 14,75
What is the registered address of Alterity Therapeutics Limited?
The registered address for Alterity Therapeutics Limited is 350 Collins Street, Melbourne, Victoria, 3000
What is the Alterity Therapeutics Limited website address?
The website address for Alterity Therapeutics Limited is alteritytherapeutics.com
Which industry sector does Alterity Therapeutics Limited operate in?
Alterity Therapeutics Limited operates in the Biotechnology & Life Sciences sector

ATHE Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion